180 related articles for article (PubMed ID: 10810406)
1. Radiation therapy for T1 glottic cancer: involvement of the anterior commissure.
Nozaki M; Furuta M; Murakami Y; Izawa Y; Iwasaki N; Takahashi H; Watanabe K
Anticancer Res; 2000; 20(2B):1121-4. PubMed ID: 10810406
[TBL] [Abstract][Full Text] [Related]
2. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
4. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
[TBL] [Abstract][Full Text] [Related]
5. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience.
Reddy SP; Hong RL; Nagda S; Emami B
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1389-94. PubMed ID: 17869013
[TBL] [Abstract][Full Text] [Related]
6. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
[TBL] [Abstract][Full Text] [Related]
7. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy of T1 and T2 glottic cancer: analysis of anterior commissure involvement.
Hirota S; Soejima T; Obayashi K; Hishikawa Y; Honda K; Okamoto Y; Maeda H; Takada Y; Inoue K; Kinishi M; Amatsu M; Kimura S
Radiat Med; 1996; 14(6):297-302. PubMed ID: 9132809
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of EGF receptor expression in early glottic cancer.
Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
[TBL] [Abstract][Full Text] [Related]
12. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection.
Chone CT; Yonehara E; Martins JE; Altemani A; Crespo AN
Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):882-7. PubMed ID: 17875854
[TBL] [Abstract][Full Text] [Related]
13. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy.
Goleń M; Składowski K; Maciejewski B
Neoplasma; 1999; 46(1):66-71. PubMed ID: 10355537
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy of T1N0 neoplasms of the glottis. Analysis of the parameters that influence local control].
Bolner A; Valentini A; Amichetti M; Busana L; Fellin G; Menegotti L; Nassivera E; Pani G; Romano M
Radiol Med; 1995 Dec; 90(6):804-7. PubMed ID: 8685467
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system.
Murakami R; Nishimura R; Baba Y; Furusawa M; Ogata N; Yumoto E; Yamashita Y
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):471-5. PubMed ID: 15667969
[TBL] [Abstract][Full Text] [Related]
16. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
[TBL] [Abstract][Full Text] [Related]
17. T1 glottic carcinoma involving the posterior commissure.
Shvero J; Shvili I; Mizrachi A; Shpitzer T; Nageris B; Koren R; Hadar T
Laryngoscope; 2009 Jun; 119(6):1116-9. PubMed ID: 19308987
[TBL] [Abstract][Full Text] [Related]
18. [Stage 1 glottic laryngeal carcinoma: observations on 76 cases treated with transcutaneous radiotherapy].
Bonetta A; Morrica B; Zingoni A; Caraffini B
Radiol Med; 1996 Jun; 91(6):802-4. PubMed ID: 8830370
[TBL] [Abstract][Full Text] [Related]
19. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
[TBL] [Abstract][Full Text] [Related]
20. Role of radiotherapy in early glottic carcinoma.
Smee RI; Meagher NS; Williams JR; Broadley K; Bridger GP
Head Neck; 2010 Jul; 32(7):850-9. PubMed ID: 20029987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
